Markets.com Logo

ACCD

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    7.0558$
  • Previous Close
    7.0558$
  • 52 Week Change
    4.97$
  • Day Range
    0.00$
  • 52 Week High/Low
    3.08$ - 8.05$
  • Dividend Per Share
    --
  • Market cap
    576 M$
  • EPS
    --
  • Beta
    2.104
  • Volume
    --

About

ACCD.US is the stock ticker symbol for Accolade, Inc., a personalized health and benefits solution company based in Plymouth Meeting, Pennsylvania. Accolade uses a combination of data, technology, and human interaction to help individuals navigate the healthcare system, understand their benefits, and make informed decisions about their health. The company's services are offered to employers and health plans as a way to improve employee engagement, reduce healthcare costs, and improve health outcomes. Accolade is publicly traded on the Nasdaq Stock Market under the ticker symbol ACCD.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Acorda Therapeutics, Inc. (ACCD.US) stock price is influenced by several factors: Clinical Trial Results: Positive or negative data from Acorda's clinical trials for new or existing drugs can significantly impact investor sentiment. Regulatory Decisions: FDA approvals, rejections, or delays for Acorda's drug candidates directly affect future revenue potential. Financial Performance: The company's revenue, profitability, cash flow, and debt levels influence investor confidence. Competition: The emergence of competing drugs or therapies in Acorda's target markets can reduce market share and revenue. Market Conditions: Broader market trends, economic conditions, and overall investor sentiment towards the biotech sector can impact ACCD. Partnerships/Acquisitions: Any strategic alliances, collaborations, or potential acquisitions involving Acorda can affect its stock price. Management Changes: Changes in leadership or key personnel can sometimes impact investor perception of the company's direction. Patent Protection: The strength and duration of Acorda's patent portfolio for its products are crucial for maintaining market exclusivity. Disease Prevalence: Changes in the prevalence or diagnosis rates of the diseases Acorda's drugs treat can affect demand.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--